Show simple item record

International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations.

dc.contributor.authorKaufmann, Manfred
dc.contributor.authorVon Minckwitz, Gunter
dc.contributor.authorSmith, Roy
dc.contributor.authorValero, Vicente
dc.contributor.authorGianni, Luca
dc.contributor.authorEiermann, Wolfgang
dc.contributor.authorHowell, Anthony
dc.contributor.authorCosta, Serban Dan
dc.contributor.authorBeuzeboc, Philippe
dc.contributor.authorUntch, Michael
dc.contributor.authorBlohmer, Jens-Uwe
dc.contributor.authorSinn, Hans-Peter
dc.contributor.authorSittek, Rolf
dc.contributor.authorSouchon, Rainer
dc.contributor.authorTulusan, Augustinos H
dc.contributor.authorVolm, Tanja
dc.contributor.authorSenn, Hans-Jörg
dc.date.accessioned2009-08-28T10:07:39Z
dc.date.available2009-08-28T10:07:39Z
dc.date.issued2003-07-01
dc.identifier.citationInternational expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations. 2003, 21 (13):2600-8 J. Clin. Oncol.en
dc.identifier.issn0732-183X
dc.identifier.pmid12829681
dc.identifier.doi10.1200/JCO.2003.01.136
dc.identifier.urihttp://hdl.handle.net/10541/79045
dc.description.abstractPrimary systemic therapy (PST) represents the standard of care in patients with locally advanced breast cancer. In addition, there is increasing information on PST in operable breast disease that supports the use of PST in routine practice. However, current regimens and techniques vary. To address this concern, a group of representatives from breast cancer clinical research groups in France, Germany, Italy, the United Kingdom, and the United States reviewed all available data on prospective randomized trials in this setting. Recommendations are made regarding terminology, indications, regimen, diagnosis before treatment, monitoring of efficacy, tumor localization, surgery, pathologic evaluation, and postoperative treatment.
dc.language.isoenen
dc.subjectCancer Stagingen
dc.subjectBreast Canceren
dc.subject.meshAntineoplastic Combined Chemotherapy Protocols
dc.subject.meshBreast Neoplasms
dc.subject.meshEvidence-Based Medicine
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshInternational Cooperation
dc.subject.meshNeoadjuvant Therapy
dc.subject.meshNeoplasm Staging
dc.subject.meshPatient Selection
dc.subject.meshRandomized Controlled Trials as Topic
dc.titleInternational expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations.en
dc.contributor.departmentDepartment of Gynecology and Obstetrics, Goethe University, Frankfurt am Main, Germany. M.Kaufmann@em.uni-frankfurt.deen
dc.identifier.journalJournal of Clinical Oncologyen
html.description.abstractPrimary systemic therapy (PST) represents the standard of care in patients with locally advanced breast cancer. In addition, there is increasing information on PST in operable breast disease that supports the use of PST in routine practice. However, current regimens and techniques vary. To address this concern, a group of representatives from breast cancer clinical research groups in France, Germany, Italy, the United Kingdom, and the United States reviewed all available data on prospective randomized trials in this setting. Recommendations are made regarding terminology, indications, regimen, diagnosis before treatment, monitoring of efficacy, tumor localization, surgery, pathologic evaluation, and postoperative treatment.


This item appears in the following Collection(s)

Show simple item record